Marc Garnick M.D.
Clinical Professor, Department of Medicine, Harvard Medical School
Professor, Department of Medicine, Beth Israel Deaconess Medical Center
Contact Info
Marc Garnick
Beth Israel Deaconess Medical Center
330 Brookline Avenue, Harvard Institutes of Medicine
Boston, MA, 02215
Mailstop: HIM 1049
Phone: 6176679187
Fax: 6177311908
mgarnick@bidmc.harvard.edu
Phone: 6176675288
Fax:
sdowling@caregroup.harvard.edu
Beth Israel Deaconess Medical Center
330 Brookline Avenue, Harvard Institutes of Medicine
Boston, MA, 02215
Mailstop: HIM 1049
Phone: 6176679187
Fax: 6177311908
mgarnick@bidmc.harvard.edu
Assistant
Sylvia DowlingPhone: 6176675288
Fax:
sdowling@caregroup.harvard.edu
DF/HCC Program Affiliation
Member, Prostate Cancer ProgramResearch Abstract
Dr. Garnick's predominant interest is urologic cancer, with a specialization in clinical investigation related to prostate cancer. Dr. Garnick is co-director of the Barry Hershey Foundation. In addition to his academic affiliation with Harvard Medical School and the Beth Israel Deaconess Medical Center, he is Chief Medical Officer and the Executive Vice President of PRAECIS Pharmaceuticals, Inc. where he is involved with the clinical development of a novel and potent GnRH antagonist, Abarelix.Publications
- Garnick MB, Fair WR. Combating prostate cancer. Sci Am 1998 Dec; 279(6):74-83
PMID: 9828467
